Angiotensin Type 1 Receptor-Dependent Internalization of SARS-CoV-2 by Angiotensin-Converting Enzyme 2

Hypertension. 2021 Apr;77(4):e42-e43. doi: 10.1161/HYPERTENSIONAHA.120.16795. Epub 2021 Jan 20.

Authors

Blessing O Ogunlade¹, Eric Lazartigues^{2

3

4}, Catalin M Filipeanu¹

Affiliations

¹ From the Department of Pharmacology, College of Medicine, Howard University, Washington, DC (B.O.O., C.M.F.).
² Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans (E.L.).
³ Southeast Louisiana Veterans Health Care Systems, New Orleans (E.L.).
⁴ Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans (E.L.).

No abstract available

Keywords: angiotensin II; angiotensin-converting enzyme 2; cardiovascular diseases; coronavirus; receptor, angiotensin, type 1.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Angiotensin II / metabolism
Angiotensin-Converting Enzyme 2
COVID-19*
Diabetes Mellitus, Type 2*
Humans
Peptidyl-Dipeptidase A / metabolism
Receptor, Angiotensin, Type 1
Renin-Angiotensin System
SARS-CoV-2

Substances

Receptor, Angiotensin, Type 1
Angiotensin II
Peptidyl-Dipeptidase A
Angiotensin-Converting Enzyme 2

Grants and funding